Nrf2 as a potential mediator of cardiovascular risk in metabolic diseases (2019)
- Authors:
- USP affiliated authors: PASSAGLIA, RITA DE CASSIA ALEIXO TOSTES - FMRP ; RODRIGUES, DANIEL - FMRP ; COSTA, RAFAEL MENEZES DA - FMRP ; PEREIRA, CAMILA ANDRÉ - FMRP ; SILVA, JOSIANE FERNANDES DA - FMRP ; ALVES, JULIANO VILELA - FMRP
- Unidade: FMRP
- DOI: 10.3389/fphar.2019.00382
- Subjects: ESTRESSE OXIDATIVO; DOENÇAS CARDIOVASCULARES; DOENÇAS METABÓLICAS
- Keywords: Oxidative stress; Cardiovascular risk; Metabolic diseases; Therapeutic target
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Frontiers in Pharmacology
- ISSN: 1663-9812
- Volume/Número/Paginação/Ano: v. 10, art. 382, 2019
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
COSTA, Rafael Menezes da et al. Nrf2 as a potential mediator of cardiovascular risk in metabolic diseases. Frontiers in Pharmacology, v. 10, 2019Tradução . . Disponível em: https://doi.org/10.3389/fphar.2019.00382. Acesso em: 27 dez. 2025. -
APA
Costa, R. M. da, Rodrigues, D., Pereira, C. A., Silva, J. F. da, Alves, J. V., Lobato, N. S., & Tostes, R. de C. A. (2019). Nrf2 as a potential mediator of cardiovascular risk in metabolic diseases. Frontiers in Pharmacology, 10. doi:10.3389/fphar.2019.00382 -
NLM
Costa RM da, Rodrigues D, Pereira CA, Silva JF da, Alves JV, Lobato NS, Tostes R de CA. Nrf2 as a potential mediator of cardiovascular risk in metabolic diseases [Internet]. Frontiers in Pharmacology. 2019 ; 10[citado 2025 dez. 27 ] Available from: https://doi.org/10.3389/fphar.2019.00382 -
Vancouver
Costa RM da, Rodrigues D, Pereira CA, Silva JF da, Alves JV, Lobato NS, Tostes R de CA. Nrf2 as a potential mediator of cardiovascular risk in metabolic diseases [Internet]. Frontiers in Pharmacology. 2019 ; 10[citado 2025 dez. 27 ] Available from: https://doi.org/10.3389/fphar.2019.00382 - Aldosterone negatively regulates Nrf2 activity: an additional mechanism contributing to oxidative stress and vascular dysfunction by Aldosterone
- Lysophosphatidylcholine induces oxidative stress in human endothelial cells via NOX5 activation: implications in atherosclerosis
- Pharmacological activation of nuclear factor erythroid 2-related factor-2 prevents hyperglycemia-induced renal oxidative damage: possible involvement of O-GlcNAcylation
- Vascular stress signaling in hypertension
- Caryocar brasiliense induces vasorelaxation through endothelial Ca2+/calmodulin and PI3K/Akt/eNOS-dependent signaling pathways in rats
- Decreased expression of neuronal nitric oxide synthase contributes to the endothelial dysfunction associated with cigarette smoking in human
- Activation of PI3K/Akt pathway mediated by estrogen receptors accounts for estrone-induced vascular activation of cGMP signaling
- Testosterone contributes to vascular dysfunction in young mice fed a high fat Diet by promoting nuclear factor E2–related factor 2 downregulation and oxidative stress
- Aldosterona via receptor mineralocorticoide reduz a atividade de Nrf2 e promove disfunção vascular
- Protective role of endothelial fibulin-4 in valvulo-arterial integrity
Informações sobre o DOI: 10.3389/fphar.2019.00382 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
